Oventus Medical (ASX:OVN) COGS-to-Revenue : 0.48 (As of Dec. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical COGS-to-Revenue?

Oventus Medical's Cost of Goods Sold for the six months ended in Dec. 2021 was A$0.26 Mil. Its Revenue for the six months ended in Dec. 2021 was A$0.55 Mil.

Oventus Medical's COGS to Revenue for the six months ended in Dec. 2021 was 0.48.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Oventus Medical's Gross Margin % for the six months ended in Dec. 2021 was 52.35%.

Oventus Medical COGS-to-Revenue Historical Data

The historical data trend for Oventus Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical COGS-to-Revenue Chart

Oventus Medical Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

COGS-to-Revenue

0.55

0.63

Oventus Medical Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
COGS-to-Revenue	Get a 7-Day Free Trial						0.54	0.56	0.54	0.72	0.48

Oventus Medical COGS-to-Revenue Calculation

Oventus Medical's COGS to Revenue for the fiscal year that ended in Jun. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.688	/	1.09
	=	0.63

Oventus Medical's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.264	/	0.554
	=	0.48

Oventus Medical (ASX:OVN) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Oventus Medical's Gross Margin % for the six months ended in Dec. 2021 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.264 / 0.554
	=	52.35 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Oventus Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oventus Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Oventus Medical (ASX:OVN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068

Website

https://www.o2vent.com

Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines